# EDGAR Filing Document

**Accession Number:** 0001993440
**File Stem:** 0001085146-25-005549
**Filing Date:** 2025-8
**Character Count:** 20672
**Document Hash:** c6a58ad5c40eea648730bc36fbb6b545
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001085146-25-005549.hdr.sgml**: 20250827

**ACCESSION NUMBER**: 0001085146-25-005549

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250827

**EFFECTIVENESS DATE**: 20250827

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** First Turn Management, LLC
- **CENTRAL INDEX KEY:** 0001993440

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-23631
- **FILM NUMBER:** 251264895

**BUSINESS ADDRESS:**
- **STREET 1:** 1155 CAMINO DEL MAR, SUITE 734
- **CITY:** DEL MAR
- **STATE:** CA
- **ZIP:** 92014
- **BUSINESS PHONE:** 858-759-4545

**MAIL ADDRESS:**
- **STREET 1:** 1155 CAMINO DEL MAR, SUITE 734
- **CITY:** DEL MAR
- **STATE:** CA
- **ZIP:** 92014

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001993440

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** First Turn Management, LLC

**Address:** 1155 CAMINO DEL MAR, SUITE 734, DEL MAR, CA 92014

**Telephone number:** 858-381-8009

**Name of agent for service:** COGENCY GLOBAL INC.

**Agent Address:** 850 NEW BURTON ROAD SUITE 201, DOVER, DE 19904

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-23631

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                   | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                     | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| ADMA Biologics, Inc.             | 000899104 | 06/04/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          51611 |                0 | FOR         |                                    51611 | FOR                         |  |
| ADMA Biologics, Inc.             | 000899104 | 06/04/2025     | To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers.                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          51611 |                0 | 1 YEAR      |                                    51611 | FOR                         |  |
| Apogee Therapeutics, Inc.        | 03770N101 | 06/17/2025     | Vote on the frequency of future advisory votes to approve our named executive officers' compensation.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          18436 |                0 | 1 YEAR      |                                    18436 | FOR                         |  |
| Axsome Therapeutics, Inc.        | 05464T104 | 06/06/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |           8726 |                0 | FOR         |                                     8726 | FOR                         |  |
| Biohaven Ltd.                    | G1110E107 | 05/05/2025     | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          11528 |                0 | AGAINST     |                                    11528 | AGAINST                     |  |
| Boston Scientific Corporation    | 101137107 | 05/01/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          13825 |                0 | FOR         |                                    13825 | FOR                         |  |
| BridgeBio Pharma, Inc.           | 10806X102 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          47152 |                0 | AGAINST     |                                    47152 | AGAINST                     |  |
| Disc Medicine, Inc.              | 254604101 | 06/11/2025     | To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |           1970 |                0 | FOR         |                                     1970 | FOR                         |  |
| Disc Medicine, Inc.              | 254604101 | 06/11/2025     | To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to the Company's named executive officers.                                                                                             | SECTION 14A SAY-ON-PAY VOTES |           1970 |                0 | 1 YEAR      |                                     1970 | FOR                         |  |
| Glaukos Corporation              | 377322102 | 05/29/2025     | Approval, on an advisory basis, of the compensation of the Company"s named executive officers.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |           8069 |                0 | FOR         |                                     8069 | FOR                         |  |
| Guardant Health, Inc.            | 40131M109 | 06/18/2025     | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          24226 |                0 | FOR         |                                    24226 | FOR                         |  |
| Harrow, Inc.                     | 415858109 | 06/18/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement.                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          15691 |                0 | FOR         |                                    15691 | FOR                         |  |
| Harrow, Inc.                     | 415858109 | 06/18/2025     | To approve, on a non-binding advisory basis, the frequency of a stockholder advisory vote on the compensation of the Company's named executive officers.                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          15691 |                0 | 1 YEAR      |                                    15691 | FOR                         |  |
| HealthEquity, Inc.               | 42226A107 | 06/26/2025     | To approve, on a non-binding, advisory basis, the fiscal 2025 compensation paid to our named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |           6441 |                0 | FOR         |                                     6441 | FOR                         |  |
| Immunovant, Inc.                 | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |           3620 |                0 | FOR         |                                     3620 | FOR                         |  |
| Insmed Incorporated              | 457669307 | 05/15/2025     | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          31006 |                0 | FOR         |                                    31006 | FOR                         |  |
| Insulet Corporation              | 45784P101 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of certain executive officers.                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |           3786 |                0 | FOR         |                                     3786 | FOR                         |  |
| Intuitive Surgical, Inc.         | 46120E602 | 05/01/2025     | To approve, by advisory vote, the compensation of the Company's Named Executive Officers.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |           3092 |                0 | FOR         |                                     3092 | FOR                         |  |
| Janux Therapeutics, Inc.         | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ( Say-On-Pay ), as disclosed in the accompanying Proxy Statement.                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          33985 |                0 | FOR         |                                    33985 | FOR                         |  |
| Janux Therapeutics, Inc.         | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          33985 |                0 | 1 YEAR      |                                    33985 | FOR                         |  |
| KalVista Pharmaceuticals, Inc.   | 483497103 | 10/03/2024     | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          86791 |                0 | AGAINST     |                                    86791 | AGAINST                     |  |
| Merus N.V                        | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          28317 |                0 | FOR         |                                    28317 | FOR                         |  |
| Mirum Pharmaceuticals, Inc.      | 604749101 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company s named executive officers, as disclosed in the proxy statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          34431 |                0 | FOR         |                                    34431 | FOR                         |  |
| MoonLake Immunotherapeutics      | 61559X104 | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          13950 |                0 | FOR         |                                    13950 | FOR                         |  |
| Natera, Inc.                     | 632307104 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          10524 |                0 | FOR         |                                    10524 | FOR                         |  |
| NewAmsterdam Pharma Company N.V. | N62509109 | 06/04/2025     | Non-binding, advisory vote to approve the 2024 compensation of named executive officers.                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          19682 |                0 | FOR         |                                    19682 | FOR                         |  |
| NewAmsterdam Pharma Company N.V. | N62509109 | 06/04/2025     | Non-binding, advisory vote regarding frequency of future shareholders' advisory votes on the compensation of named executive officers.                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          19682 |                0 | 1 YEAR      |                                    19682 | FOR                         |  |
| Nuvalent, Inc.                   | 670703107 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          26424 |                0 | FOR         |                                    26424 | FOR                         |  |
| Radnet, Inc.                     | 750491102 | 06/10/2025     | An advisory vote to approve the compensation of the Company's Named Executive Officers.                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |           9739 |                0 | AGAINST     |                                     9739 | AGAINST                     |  |
| Revolution Medicines, Inc.       | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). | SECTION 14A SAY-ON-PAY VOTES |          23791 |                0 | FOR         |                                    23791 | FOR                         |  |
| SpringWorks Therapeutics, Inc.   | 85205L107 | 05/14/2025     | Non-binding advisory vote on executive compensation                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          23423 |                0 | FOR         |                                    23423 | FOR                         |  |
| SpringWorks Therapeutics, Inc.   | 85205L107 | 06/26/2025     | A proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger.                                                            | SECTION 14A SAY-ON-PAY VOTES |          15372 |                0 | FOR         |                                    15372 | FOR                         |  |
| TG Therapeutics, Inc.            | 88322Q108 | 06/12/2025     | An advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          32405 |                0 | AGAINST     |                                    32405 | AGAINST                     |  |
| Vera Therapeutics, Inc.          | 92337R101 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          48295 |                0 | FOR         |                                    48295 | FOR                         |  |
| Vera Therapeutics, Inc.          | 92337R101 | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          48295 |                0 | 1 YEAR      |                                    48295 | FOR                         |  |
| Verona Pharma plc                | 925050106 | 04/24/2025     | To Approve, On An Advisory (Non-Binding) Basis, The Compensation Of The Company's Named Executive Officers.                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          39845 |                0 | AGAINST     |                                    39845 | AGAINST                     |  |
| Xenon Pharmaceuticals Inc.       | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers;                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          54980 |                0 | FOR         |                                    54980 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** First Turn Management, LLC

**By (Signature):** Catherine Newcomb

**By (Printed Signature):** Catherine Newcomb

**By (Title):** Chief Compliance Officer

**Date:** 08/27/2025